BRCA2 and ovarian cancer: Figure 3 shows dot plots that describe the risk of death in relation to the outcome (Hazard Ratio, HR), without considering the false discovery rate (FDR), for each of the evaluated genes in BRCA1 and BRCA2, breast, and ovarian cancer.